Programme Day Two
Thursday 28 January 2010
8:30 Registration
09:00
Debbie Allison
Senior Director, Head Scientific Competitive Intelligence
MERCK & CO
Opening remarks from the Chair
9:10
Roundtable morning
Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of competitive intelligence in pharma.
Dr. Yulia V. Aspinall
Senior Manager Global Competitive Intelligence
ACTELION
Roundtable 1
Discussing the acceptance and reputation of CI as a profession and outlining aspects that still need to improve
Legitimising CI within your corporation to ensure acceptance and widespread use of information
Debbie Allison
Senior Director, Head Scientific Competitive Intelligence
MERCK & CO
Roundtable 2
Identifying measuring strategies for CI to ensure ROI
Uncovering efficient methods on how to measure your CI efforts to improve your strategies and maximise the ROI.
Dr. Robert F. Siegmund
MBA, Director Global Commercial Analytics
ACTELION
Roundtable 3
Demonstrating the value of CI in the pharmaceutical and biotech industry and predicting future trends
Discussing the value and ROI of CI and learning about the latest trends in the industry to be prepared and keep your competitive edge.
Richard Withers
Managing Partner
DEALLUS GROUP
Roundtable 4
Do strategy workshop provide the nest analysis?
Learning how to develop your organisational capability with war gaming and scenario analysis.
Dr. Pablo Prados
Head, Scientific Competitive Intelligence
SANOFI-AVENTIS
Roundtable 5
Analysing the value of your R&D CI function: scope, strategy, performance
Learn how to set your R&D CI goals, evaluate your efforts and measure your success
12:30 Lunch
Uncovering the CI environment in today’s economic climate
13:30
Jonas Pedersen
COO
DEALLUS
Tear down the walls! Combining CI and MR delivers outstanding competitor strategy insightt
- Aligning CI to business objectives
- Combining market research and CI to deliver on these objectives
- Utilising the combined approach to build client relationships
Uncovering the CI environment in today’s economic climate
13:45
Jean-François Loewenthal
Associate Director
Intelligences SARL
From real life to the virtual and back again: ecology of counterfeit medicines sale on the Internet
- Uncovering the facts about counterfeit medicines and how they endanger your company
- Detailing the criminal supply chain – from rogue industry manufacturing bulk products to the retailers advertising their products for online customers
- Showing how a full-blown criminal economy is supporting those sales
- Outlining an intelligence posture to assess the risk and identify perpetrators
14:15
Astrid Scherer
Head of Competitive Intelligence for Diagnostic Imaging
BAYER SCHERING PHARMA
Can CI contribute to map out priorities within portfolio management?
- Effectively analysing external, competitive factors to ensure effective decision making on portfolio products
14:45 Afternoon refreshments
15:15
Jonas Pedersen
COO
DEALLUS
Tear down the walls! Combining CI and MR delivers outstanding competitor strategy insight
- Aligning CI to business objectives
- Combining market research and CI to deliver on these objectives
- Utilising the combined approach to build client relationships
15:45
Dr. Pablo Prados
Head, Scientific Competitive Intelligence
SANOFI-AVENTIS
Rethinking a R&D CI function in times of change
- Handling new priorities and goals, securing internal sponsors, establishing rapport with new stakeholders
- Functional and organizational positioning; role in contributing to the formulation of new strategy
- Helping address future R&D directions and challenges
- Assessing the impact of CI on decision making in the new environment
- Need for appropriate CI performance measuring and monitoring tools
- Future of a CI function
16:15
Closing remarks from the Chair
16:20 Champagne prize draw
16:25 Close of conference
